ARTIVA BIOTHERAPEUTICS INC (ARTV) Fundamental Analysis & Valuation

NASDAQ:ARTV • US04317A1079

Current stock price

6.81 USD
+0.01 (+0.15%)
At close:
6.6512 USD
-0.16 (-2.33%)
After Hours:

This ARTV fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

0

1. ARTV Profitability Analysis

1.1 Basic Checks

  • In the past year ARTV has reported negative net income.
  • ARTV had a negative operating cash flow in the past year.
  • In the past 5 years ARTV always reported negative net income.
  • In the past 5 years ARTV always reported negative operating cash flow.
ARTV Yearly Net Income VS EBIT VS OCF VS FCFARTV Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2023 2024 2025 -20M -40M -60M -80M

1.2 Ratios

  • ARTV has a Return On Assets of -64.05%. This is in the lower half of the industry: ARTV underperforms 61.70% of its industry peers.
  • ARTV has a Return On Equity (-76.26%) which is in line with its industry peers.
Industry RankSector Rank
ROA -64.05%
ROE -76.26%
ROIC N/A
ROA(3y)-40.85%
ROA(5y)-41.8%
ROE(3y)-54.69%
ROE(5y)-59.61%
ROIC(3y)N/A
ROIC(5y)N/A
ARTV Yearly ROA, ROE, ROICARTV Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 2024 2025 -20 -40 -60

1.3 Margins

  • ARTV does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
ARTV Yearly Profit, Operating, Gross MarginsARTV Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022 2023 2024 2025 -5K -10K -15K -20K -25K

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

7

2. ARTV Health Analysis

2.1 Basic Checks

  • ARTV does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • Compared to 1 year ago, ARTV has more shares outstanding
  • The debt/assets ratio for ARTV has been reduced compared to a year ago.
ARTV Yearly Shares OutstandingARTV Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 2024 2025 5M 10M 15M 20M
ARTV Yearly Total Debt VS Total AssetsARTV Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 2024 2025 50M 100M 150M 200M

2.2 Solvency

  • Based on the Altman-Z score of -0.08, we must say that ARTV is in the distress zone and has some risk of bankruptcy.
  • The Altman-Z score of ARTV (-0.08) is comparable to the rest of the industry.
  • There is no outstanding debt for ARTV. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -0.08
ROIC/WACCN/A
WACC9.19%
ARTV Yearly LT Debt VS Equity VS FCFARTV Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 2024 2025 0 50M -50M 100M 150M

2.3 Liquidity

  • ARTV has a Current Ratio of 8.61. This indicates that ARTV is financially healthy and has no problem in meeting its short term obligations.
  • The Current ratio of ARTV (8.61) is better than 73.89% of its industry peers.
  • ARTV has a Quick Ratio of 8.61. This indicates that ARTV is financially healthy and has no problem in meeting its short term obligations.
  • With a decent Quick ratio value of 8.61, ARTV is doing good in the industry, outperforming 73.89% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 8.61
Quick Ratio 8.61
ARTV Yearly Current Assets VS Current LiabilitesARTV Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 2024 2025 50M 100M 150M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

1

3. ARTV Growth Analysis

3.1 Past

  • The earnings per share for ARTV have decreased strongly by -17.51% in the last year.
  • Looking at the last year, ARTV shows a very negative growth in Revenue. The Revenue has decreased by -100.00% in the last year.
EPS 1Y (TTM)-17.51%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-28.79%
Revenue 1Y (TTM)-100%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

  • The Earnings Per Share is expected to grow by 11.85% on average over the next years. This is quite good.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y0.48%
EPS Next 2Y18.17%
EPS Next 3Y2.54%
EPS Next 5Y11.85%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
ARTV Yearly Revenue VS EstimatesARTV Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2022 2023 2024 2028 2029 2030 2031 2032 2033 200M 400M 600M
ARTV Yearly EPS VS EstimatesARTV Yearly EPS VS EstimatesYearly EPS VS Estimates 2024 2025 2026 2027 2028 2029 2030 -1 -2 -3 -4 -5

More info and screens

Find the best growth stocksShow best growing peers

0

4. ARTV Valuation Analysis

4.1 Price/Earnings Ratio

  • ARTV reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • Also next year ARTV is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ARTV Price Earnings VS Forward Price EarningsARTV Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30 40 50

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ARTV Per share dataARTV EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2 4

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y18.17%
EPS Next 3Y2.54%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. ARTV Dividend Analysis

5.1 Amount

  • ARTV does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

ARTV Fundamentals: All Metrics, Ratios and Statistics

ARTIVA BIOTHERAPEUTICS INC

NASDAQ:ARTV (4/10/2026, 8:06:33 PM)

After market: 6.6512 -0.16 (-2.33%)

6.81

+0.01 (+0.15%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)03-10
Earnings (Next)05-07
Inst Owners65%
Inst Owner Change0%
Ins Owners8.9%
Ins Owner Change24.25%
Market Cap168.34M
Revenue(TTM)N/A
Net Income(TTM)-83.86M
Analysts85
Price Target17.34 (154.63%)
Short Float %0.87%
Short Ratio0.86
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-0.01%
Min EPS beat(2)-0.85%
Max EPS beat(2)0.83%
EPS beat(4)1
Avg EPS beat(4)-5.07%
Min EPS beat(4)-14.53%
Max EPS beat(4)0.83%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)2%
EPS NQ rev (3m)2%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 1.53
P/tB 1.53
EV/EBITDA N/A
EPS(TTM)-3.43
EYN/A
EPS(NY)-3.41
Fwd EYN/A
FCF(TTM)-3.21
FCFYN/A
OCF(TTM)-3.1
OCFYN/A
SpS0
BVpS4.45
TBVpS4.45
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -64.05%
ROE -76.26%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-40.85%
ROA(5y)-41.8%
ROE(3y)-54.69%
ROE(5y)-59.61%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score2
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 99.61%
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 8.61
Quick Ratio 8.61
Altman-Z -0.08
F-Score2
WACC9.19%
ROIC/WACCN/A
Cap/Depr(3y)89.93%
Cap/Depr(5y)301.78%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-17.51%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-28.79%
EPS Next Y0.48%
EPS Next 2Y18.17%
EPS Next 3Y2.54%
EPS Next 5Y11.85%
Revenue 1Y (TTM)-100%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-34.53%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-42.5%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-39.47%
OCF growth 3YN/A
OCF growth 5YN/A

ARTIVA BIOTHERAPEUTICS INC / ARTV Fundamental Analysis FAQ

What is the ChartMill fundamental rating of ARTIVA BIOTHERAPEUTICS INC (ARTV) stock?

ChartMill assigns a fundamental rating of 2 / 10 to ARTV.


Can you provide the valuation status for ARTIVA BIOTHERAPEUTICS INC?

ChartMill assigns a valuation rating of 0 / 10 to ARTIVA BIOTHERAPEUTICS INC (ARTV). This can be considered as Overvalued.


Can you provide the profitability details for ARTIVA BIOTHERAPEUTICS INC?

ARTIVA BIOTHERAPEUTICS INC (ARTV) has a profitability rating of 0 / 10.


What is the earnings growth outlook for ARTIVA BIOTHERAPEUTICS INC?

The Earnings per Share (EPS) of ARTIVA BIOTHERAPEUTICS INC (ARTV) is expected to grow by 0.48% in the next year.